GenVec (GNVC)
GenVec Earnings Per Share: -0.25
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
GNVC Earnings Per Share Rankings
| Overall | 9th percentile | 4005 of 4431 |
| Sector | 16th percentile | 421 of 507 in Healthcare |
| Industry | 26th percentile | 117 of 160 in Biotechnology |
GNVC Earnings Per Share Range, Past 5 Years
| Minimum | -0.80 | Mar 2008 |
| Maximum | -0.07 | Dec 2010 |
| Average | -0.4245 |
About Earnings per Share
Earnings per share (EPS) the amount of income that "belongs" to each share of common stock. An important tool for investors, EPS is often used in determining the value of a stock.
The average number of shares outstanding (the denominator of the EPS formula) is usually calculated by averaging the number of shares at the beginning of the earning period and the number of shares at the end of the period. For example, if a company earned $1 million in 2009 and had 900,000 shares at the beginning of 2009 and 1.1 million shares at the end of 2009, the 2009 EPS would be $1 million/[(.9 million shares + 1.1 million shares)/2] = $1/share.
EPS is generally reported in annualized form from the most recent fiscal year. From time to time, you will see the abbreviation (ttm) associated with earnings per share. That means that the earnings number is a sum of the previous four quarters, which is not necessarily the same as the previous fiscal year.
Learn More
You may also be interested in these GNVC related companies
GNVC News
GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
May 03, 8:30AM PR Newswire
May 03, 8:30AM PR Newswire
Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against GenVec, Inc.
Jan 10, 3:52PM Business Wire
Jan 10, 3:52PM Business Wire
GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011
Nov 02, 8:40AM PR Newswire
Nov 02, 8:40AM PR Newswire
$GNVC http://stks.co/Axr trying to sneak out here. Sneak sneak sneak.
about 260 days ago by retailtrader
about 260 days ago by retailtrader
In LiveCharts today, we analyzed the charts on $MOTR $UCO $DF $AAPL $SPY $LLNW KKD $GNVC $HSOL and REMX http://stk.ly/mpKIaS
about 341 days ago by SharePlanner
about 341 days ago by SharePlanner
$LPX Buying trigger : $8.04 Profit: 1.8% $GNVC Buying Trigger: $ 3.11 Profit : 4.5% $LAVA Buying Trigger $7.90 Profit: 2.27%
about 342 days ago by Trade4Me
about 342 days ago by Trade4Me
$GNVC Buying Trigger: $ 3.11 Volume change: 137% Earnings Growth: 56% Revenue Growth 82%
about 342 days ago by Trade4Me
about 342 days ago by Trade4Me
Watch List : $LAVA Buying Trigger $ 7.90 $BJRI Buying Trigger: $ 48.31 $GNVC Buying Trigger: $ 3.11
about 343 days ago by Trade4Me
about 343 days ago by Trade4Me
RT @adamfeuerstein Other bio-shells available for reverse mergers -- $TELK, $GNVC (h/t @LTbioinvestor)
about 351 days ago by chicagosean
about 351 days ago by chicagosean
$GNVC GenVec Technology Used To Restore Lost Balance Function http://stk.ly/haJmMo
about 415 days ago by mike_peace
about 415 days ago by mike_peace
$gnvc something happening, nice volume and breakout on a weak tape. risky tho
about 495 days ago by mike_peace
about 495 days ago by mike_peace
nibbled at some $GNVC today....because ya never know when a spike can occurr
about 497 days ago by beachlife
about 497 days ago by beachlife
my watchlist for week 17-21 January 2011 http://stk.ly/hPSzN9 $SOL $PTIE $ENMD $GNVC $X $MOTR $FORM
about 499 days ago by mike_peace
about 499 days ago by mike_peace
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GNVC | 2.475 | -0.03 | -1.00% | 32.40M |
| ING | 6.05 | +0.09 | +1.51% | 22.54B |
| INFY | 43.44 | +0.98 | +2.31% | 24.26B |
| INFU | 1.82 | -0.08 | -4.21% | 40.53M |
| INFN | 6.615 | +0.20 | +3.04% | 702.67M |
| INFI | 13.00 | +0.27 | +2.12% | 340.65M |
| INFA | 43.23 | +0.66 | +1.55% | 4.571B |
| INCY | 22.38 | -0.03 | -0.13% | 2.853B |
| INAP | 7.17 | +0.04 | +0.56% | 375.96M |
| IN | 5.99 | +0.44 | +7.93% | 332.06M |
